PTJ
MTCR

Paul Tudor Jones’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Paul Tudor Jones’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-239,100
Closed -$136K – 3093
2023
Q1 		$136K Sell
239,100
-70,927
-23% -$33.3K ﹤0.01% 2228
2022
Q4 		$139K Sell
310,027
-39,073
-11% -$16.2K ﹤0.01% 2189
2022
Q3 		$169K Buy
+349,100
New +$172K ﹤0.01% 2105

Paul Tudor Jones's MTCR Position: Q2 2023 in Review

Paul Tudor Jones sold out of Metacrine, Inc. Common Stock (MTCR) in Q2 2023, closing a stake of 239,100 shares — an estimated $136K sold.

Paul Tudor Jones first reported a position in MTCR in Q3 2022 and held it in 3 quarters. The position peaked at $169K in Q3 2022. 0 funds tracked by Wall St. Rank hold MTCR as of Q2 2023.

  • Paul Tudor Jones reported no remaining Metacrine, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 239,100 Metacrine, Inc. Common Stock shares in Q2 2023, an estimated $136K.
  • Paul Tudor Jones first reported a position in Metacrine, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Paul Tudor Jones's Metacrine, Inc. Common Stock position peaked at $169K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.